Journal: bioRxiv
Article Title: Ångström Resolution with Flow Immunofluorescence Localization Microscopy (FILM)
doi: 10.64898/2025.12.16.694546
Figure Lengend Snippet: (A) Overview DAPI image (using a 10× objective) of a PFA-fixed and quenched human palatine tonsil tissue section (4 µm thick) containing a follicle. White borders (dotted lines) are used to indicate the anatomic follicular zones corresponding to the germinal center (GC), mantle zone (MZ) and interfollicular region (IFR). (B) Multicolor overlay of sequential FILM acquisitions of the boxed region in A of PE-labeled IgM at 20% LED power (0.7 W cm −2 ) and APC-labeled IgD, CD81, and CD20 at 100% LED power (5.3 W cm −2 ) (10-nm pixels with 3-pixel Gaussian blurring). The sample was washed extensively with PBS under continuous flow and photobleaching before application of each successive probe. After FILM imaging, IF images were acquired (shown on the left side of the panel for comparison). (C) Zoom-in of the boxed region with Ć label in B (10-nm pixels with 3-pixel Gaussian blurring). (D) Zoom-in of boxed region in C using peak-normalized Gaussian representations for the localizations (color-coded for each marker as in B). (E) Zoom-in of boxed region in D. Colored arrows indicate individual localizations with 2.1 nm and 1.3 nm precision for IgD and CD20, respectively. (F) Zoom-in of the boxed region with F’ label in B (10-nm pixels with 3-pixel Gaussian blurring) overlaid with a conventional DAPI image (grayscale). Boxed region contains a single isolated linear CD81 structure. (G) Zoom-in of the boxed region in F, now displaying only the CD81 localizations as peak-normalized Gaussians with color-coded precision according to the colorbar. The estimated positions (centers of the Gaussians) for all 27 individual localizations lie within the overlaid strip of width 40 nm (two offset localizations toward the upper right were not considered as part of the structure). See for four additional examples of similar linear CD81 structures.
Article Snippet: α-tubulin (REA1136 REAfinityTM, h, APC, #130-119-541, Miltenyi Biotec), CD2 (REA972 REAfinityTM, h, APC, #130-116-150, Miltenyi Biotec), CD20 (REA780 REAfinityTM, h, APC, #130-111-339, Miltenyi Biotec), CD28 (REA612 REAfinityTM, h, APC, #130-118-343, Miltenyi Biotec), CD45 (REA1023 REAfinityTM, h/nhp, APC, #130-117-191, Miltenyi Biotec), CD54/ICAM-1 (REA266 REAfinityTM, h, APC, #130-120-711, Miltenyi Biotec), CD81 (REA513 REAfinityTM, h, APC, #130-119-787, Miltenyi Biotec), CD107a/LAMP1 (REA792 REAfinityTM, h, APC, #130-111-847, Miltenyi Biotec), IgD (REA740 REAfinityTM, h, APC, #130-110-644, Miltenyi Biotec), IgM (REAL689 REAdye_leaseTM, h, PE, #130-125-786, Miltenyi Biotec), Pan-Cytokeratin (REA1141 REAfinityTM, h, APC, #130-120-096, Miltenyi Biotec), β-catenin (REA480 REAfinityTM, h, APC, #130-124-444, Miltenyi Biotec), TCRα/β (REA652 REAfinityTM, h, APC, #130-113-535, Miltenyi Biotec), TOM22 (REA1185 REAfinityTM, APC, h/ms, #130-122-079, Miltenyi Biotec), DAPI Staining Solution (#130-111-570, Miltenyi Biotec), and ATTO 643 phalloidin (ATT-AD643-81, ATTO-TEC).
Techniques: Labeling, Imaging, Comparison, Marker, Isolation, Stripping Membranes